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Abstract
Background: Muscular strengthening activity (MSA) has been shown to be inversely
associated with insulin resistance (IR). The associations between quartiles of the
homeostatic model assessment of insulin resistance (HOMA-IR) and self-reported MSA
in a nationally representative sample of euglycemic U.S. adults were examined.
Methods: Sample included adult participants (≥20 years of age [n=2,543]) from the
1999-2004 National Health and Nutrition Examination Survey (NHANES). HOMA-IR
was categorized into quartiles based on every 25th percentile. No MSA was the dependent
variable.
Results: Following adjustment for covariates, those with HOMA-IR values in third
(p<0.01) and fourth (p<0.001) quartiles were found to have significantly greater odds of
reporting no MSA. Following further adjustment for non-MSA specific leisure time
physical activity, results remained significant (p<0.05 third, p<0.001 fourth). A
significant positive trend was seen across quartiles of HOMA-IR (p=0.01) for odds of
reporting no MSA.
Conclusions: Having a higher HOMA-IR value is associated with greater odds of
reporting no MSA in euglycemic U.S. adults.
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Chapter One: Introduction
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Background
Insulin resistance (IR) is characterized by the inability of the body to properly
utilize endogenous insulin in order to maintain glucose homeostasis. Insulin resistance
has been shown to be highly associated with type 2 diabetes(1,2). Moreover, studies have
also shown that IR is highly prevalent in subjects who are apparently healthy(3,4),
approximately 1/3 of euglycemic adults. Bonora et al.(1) investigated the association
between risk factors for type 2 diabetes and incidence of type 2 diabetes in white subjects
without diabetes. Results revealed that subjects in the highest quartile of IR as well as
subjects with lowered β-cell secretion rates had higher rates of incidence for type 2
diabetes (p<0.001). Currently diabetes is estimated to affect approximately 8.3% of the
population, both diagnosed and undiagnosed(5). According to a study conducted by
Boyle et al.(6), diabetes prevalence is projected to reach between 21-33% by the year
2050, depending upon incidence and mortality rates. The economic burden of diabetes in
2012 was approximately $245 billion(7), a significant increase compared to the $174
billion in 2007(8).
Many studies have shown a significant association between higher levels of IR
and cardiovascular disease (CVD)(1,9,10); all-cause mortality(11) as well as several
cardio metabolic risk factors such as obesity(12-14), inflammation(15,16),
hypertension(18), dyslipidemia(13,17,19) and hyperglycemia(13,17) in subjects without
diabetes. Hanley et al.(9) investigated the associations between higher levels of IR
(categorized into quintiles) and CVD risk in Mexican Americans and Non-Hispanic
Whites without diabetes. Results revealed a significant trend (p<0.0001) in risk for CVD
across quintiles of IR. Furthermore, a significantly increased relative risk for CVD was
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seen in those in the highest quintile of IR compared to the lowest (2.52, 95% CI 1.46–
4.36). Results also revealed a significant positive trend across quintiles for IR for several
cardio metabolic risk factors including blood pressure, high-density lipoprotein
cholesterol (negative trend [HDL-C]), low-density lipoprotein cholesterol (LDL-C),
adiposity measurements, fasting insulin and glucose and triglycerides.
Traditional Approach-Muscular Strengthening Activity and Insulin Resistance
In order to properly treat or prevent the progression of IR, physical activity (PA),
specifically muscular strengthening activity (MSA), has been investigated as a potential
modality. Traditionally, MSA (or characteristics of MSA such as lean body mass or
strength) has been investigated as the independent variable and IR as the dependent
variable(20-28). Miller et al.(24) reported a significant reduction (37.5%, p<0.05) in basal
insulin levels in response to an oral glucose tolerance test (OGTT) in eight young
healthy male subjects following a 10-week progressive MSA protocol, illustrating
decreases in peripheral IR. Furthermore, Cheng et al.(21) investigated the associations
between volumes of MSA and IR, measured via the quantitative insulin sensitivity check
index (QUICKI), in subjects without diabetes utilizing data from the 1999-2004 National
Health and Nutrition Examination Survey (NHANES). Results revealed a significant
difference in QUCIKI levels for subjects reporting ≥1 day/week of MSA (p<0.05).
Following adjustment for covariates, results remained significant in females but not
males. Significance was only seen in volumes of MSA ≥3 days/week (p<0.05) in males.
These data suggest that MSA is inversely associated with IR in apparently healthy
subjects.
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Non-traditional-Clinical Approach
A novel approach to surveillance data utilizes a model with the adverse metabolic
condition as the independent variable and the health behavior as the dependent variable.
This method provides insight into PA and MSA patterns among groups who are at greater
metabolic risk. Few studies have used this model(29-33). Zhao et al.(32) reported that
subjects with diabetes reported lower levels of total, moderate and vigorous PA compared
to those without diabetes. Furthermore, subjects with diabetes had lower odds of
reporting meeting the 2008 DHHS and 2007 American Diabetes Association PA
recommendations compared to those without. Another cross-sectional analysis conducted
by Zhao et al.(33) found similar associations between diabetes status and reported PA
patterns among adults ≥65 years of age. Churilla et al.(29) reported the prevalence of
meeting the 2008 DHHS PA recommendations to be 59.1% among participants reporting
high-cholesterol (HC) and 68.3% among participants not reporting HC (p<0.05). Another
study by Churilla et al.(30) reported significantly lowered odds (OR 0.85, 95% CI 0.820.88) for meeting the DHHS PA recommendations in subjects with hypertension
compared to those without hypertension. These studies, utilizing what could be viewed as
a clinical approach to surveillance research all illustrate that at a population level, those
with chronic conditions may be engaging in significantly lower volumes of PA, thus not
receiving the proven health benefits of leading an active lifestyle. This approach to
analyzing surveillance data may assist clinicians (e.g., physicians) in identifying those
who need lifestyle counseling and PA recommendations.
Physician Recommended Physical Activity
Barnes et al.(34) reported that the prevalence of doctors recommending exercise
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or physical activity to adult patients is approximately 32.4% and is significantly higher in
subjects with diabetes, CVD, or hypertension compared to those without. Despite these
recommendations, Zhao et al.(32) showed that subjects with diabetes report being less
active than those without diabetes. Interestingly, there have been no studies investigating
specifically the prevalence of doctor recommended PA among subjects with IR, a highly
prevalent, deleterious metabolic condition among euglycemic adults.
Prevalence of Muscular Strengthening Activity
Currently, approximately 30% of the U.S. adult population meets the 2008 DHHS
MSA recommendations of ≥2 days/week(35-38). From these prevalence estimates it can
be deduced that 70% of U.S. adults are not participating in adequate amounts of MSA,
which has been shown to reduce the risk of diabetes(39) and CVD(40) as well as reduce
levels of IR. However, no studies have investigated the MSA among euglycemic subjects
with IR.
Purpose and Research Questions
There is a paucity of literature investigating the relationship between IR and MSA
in euglycemic adults. The proposed study will investigate the potential associations
between quartiles of IR (via HOMA-IR) and self-reported MSA in euglycemic U.S.
adults. The specific research questions addressed by this study are as follows:
1. Is there a significant association between quartiles of HOMA-IR and selfreported MSA in euglycemic U.S. adults?

6

2. Is there is a significant association between quartiles of HOMA-IR and selfreported MSA in euglycemic U.S. adults adjusting for non-MSa specific leisure
time physical activity (LTPA)?
To the best of our knowledge, this is the first study to investigate these
associations utilizing HOMA-IR as the primary independent variable and MSA as the
dependent variable. This is a novel approach to the study design characterized by using
IR as an explanatory variable rather than the outcome variable. Ultimately, this study will
add to the existing literature that investigates the relationship between IR and MSA as
well as the literature utilizing metabolic health as the independent variable and health
behavior as the dependent variable.
Project Description
In this study the sample will be limited to adults ≥ 20 years of age that
participated in the 1999-2004 NHANES. Non-fasted participants, participants with prediabetes or diabetes, participants with missing data on any covariates, and pregnant
women will be excluded from this study. There are several limitations inherent to the
cross-sectional design:
1. Inability to establish causality.
2. Potential for recall bias due to the use of questionnaires to assess certain
variables.
3. The self-reported variables are subject to the social-desirability effect.
4. Residual confounding.

7

REFERENCES
1.

Bonora E, Kiechl S, Willeit J et al. Population-based incidence rates and risk
factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes
2004;53:1782-9.

2.

Zavaroni I, Bonora E, Pagliara M et al. Risk factors for coronary artery disease in
healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J
Med 1989;320:702-6.

3.

Li C, Ford ES, McGuire LC, Mokdad AH, Little RR, Reaven GM. Trends in
hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care
2006;29:2396-402.

4.

Ioannou GN, Bryson CL, Boyko EJ. Prevalence and trends of insulin resistance,
impaired fasting glucose, and diabetes. J Diabetes Complications 2007;21:363-70.

5.

Centers for Disease Control and Prevention. 2011 National Diabetes Fact Sheet.
http://www.cdc.gov/diabetes/pubs/estimates11.htm, 2011.

6.

Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the
year 2050 burden of diabetes in the US adult population: dynamic modeling of
incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29.

7.

American Diabetes Association. Economic costs of diabetes in the U.S. in 2012.
Diabetes Care 2013;36:1033-46.

8.

American Diabetes Association. Economic costs of diabetes in the U.S. In 2007.
Diabetes Care 2008;31:596-615.

8

9.

Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment
of insulin resistance in relation to the incidence of cardiovascular disease: the San
Antonio Heart Study. Diabetes Care 2002;25:1177-84.

10.

Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L. Insulin resistance in
non-diabetic subjects is associated with increased incidence of myocardial
infarction and death. Diabet Med 2002;19:470-5.

11.

Ausk KJ, Boyko EJ, Ioannou GN. Insulin resistance predicts mortality in
nondiabetic individuals in the U.S. Diabetes Care 2010;33:1179-85.

12.

Farin HM, Abbasi F, Reaven GM. Body mass index and waist circumference both
contribute to differences in insulin-mediated glucose disposal in nondiabetic
adults. Am J Clin Nutr 2006;83:47-51.

13.

McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of
insulin resistance and associated cardiovascular disease risk factors among normal
weight, overweight, and obese individuals. Metabolism 2004;53:495-9.

14.

Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and
cardiovascular disease. Recent Prog Horm Res 2004;59:207-23.

15.

Chen J, Wildman RP, Hamm LL et al. Association between inflammation and
insulin resistance in U.S. nondiabetic adults: results from the Third National
Health and Nutrition Examination Survey. Diabetes Care 2004;27:2960-5.

16.

McLaughlin T, Abbasi F, Lamendola C et al. Differentiation between obesity and
insulin resistance in the association with C-reactive protein. Circulation
2002;106:2908-12.

9

17.

Resnick HE, Jones K, Ruotolo G et al. Insulin resistance, the metabolic syndrome,
and risk of incident cardiovascular disease in nondiabetic american indians: the
Strong Heart Study. Diabetes Care 2003;26:861-7.

18.

Ferrannini E, Buzzigoli G, Bonadonna R et al. Insulin resistance in essential
hypertension. N Engl J Med 1987;317:350-7.

19.

Kim JS, Kang HT, Shim JY, Lee HR. The association between the triglyceride to
high-density lipoprotein cholesterol ratio with insulin resistance (HOMA-IR) in
the general Korean population: based on the National Health and Nutrition
Examination Survey in 2007-2009. Diabetes Res Clin Pract 2012;97:132-8.

20.

Ahmadizad S, Haghighi AH, Hamedinia MR. Effects of resistance versus
endurance training on serum adiponectin and insulin resistance index. Eur J
Endocrinol 2007;157:625-31.

21.

Cheng YJ, Gregg EW, De Rekeneire N et al. Muscle-strengthening activity and
its association with insulin sensitivity. Diabetes Care 2007;30:2264-70.

22.

Craig BW, Everhart J, Brown R. The influence of high-resistance training on
glucose tolerance in young and elderly subjects. Mech Ageing Dev 1989;49:14757.

23.

Kodama S, Shu M, Saito K et al. Even low-intensity and low-volume exercise
training may improve insulin resistance in the elderly. Intern Med 2007;46:10717.

24.

Miller WJ, Sherman WM, Ivy JL. Effect of strength training on glucose tolerance
and post-glucose insulin response. Med Sci Sports Exerc 1984;16:539-43.

10

25.

Miller JP, Pratley RE, Goldberg AP et al. Strength training increases insulin
action in healthy 50- to 65-yr-old men. J Appl Physiol (1985) 1994;77:1122-7.

26.

Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with
insulin resistance and prediabetes. Findings from the third National Health and
Nutrition Examination Survey. J Clin Endocrinol Metab 2011;96:2898-903.

27.

Barzilay JI, Cotsonis GA, Walston J et al. Insulin resistance is associated with
decreased quadriceps muscle strength in nondiabetic adults aged >or=70 years.
Diabetes Care 2009;32:736-8.

28.

Karelis AD, Tousignant B, Nantel J et al. Association of insulin sensitivity and
muscle strength in overweight and obese sedentary postmenopausal women. Appl
Physiol Nutr Metab 2007;32:297-301.

29.

Churilla JR, Johnson TM, Zippel EA. Association of physical activity volume and
hypercholesterolemia in US adults. QJM 2013;106:333-40.

30.

Churilla JR, Ford ES. Comparing physical activity patterns of hypertensive and
nonhypertensive US adults. Am J Hypertens 2010;23:987-93.

31.

Zhao G, Ford ES, Li C, Mokdad AH. Are United States adults with coronary heart
disease meeting physical activity recommendations? Am J Cardiol 2008;101:55761.

32.

Zhao G, Ford ES, Li C, Mokdad AH. Compliance with physical activity
recommendations in US adults with diabetes. Diabet Med 2008;25:221-7.

33.

Zhao G, Ford ES, Li C, Balluz LS. Physical activity in U.S. older adults with
diabetes mellitus: prevalence and correlates of meeting physical activity
recommendations. J Am Geriatr Soc 2011;59:132-7.

11

34.

Barnes PM, Schoenborn CA. Trends in adults receiving a recommendation for
exercise or other physical activity from a physician or other health professional.
NCHS Data Brief 2012:1-8.

35.

Carlson SA, Fulton JE, Schoenborn CA, Loustalot F. Trend and prevalence
estimates based on the 2008 Physical Activity Guidelines for Americans. Am J
Prev Med 2010;39:305-13.

36.

Loustalot F, Carlson SA, Kruger J, Buchner DM, Fulton JE. Musclestrengthening activities and participation among adults in the United States. Res Q
Exerc Sport 2013;84:30-8.

37.

Centers for Disease Control and Prevention. Adult Participation in Aerobic and
Muscle-Strengthening Physical Activities-United States, 2011.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6217a2.htm, 2013.

38.

Centers for Disease Control and Prevention.Trends in strength training--United
States, 1998-2004. MMWR Morb Mortal Wkly Rep 2006;55:769-72.

39.

Grøntved A, Rimm EB, Willett WC, Andersen LB, Hu FB. A prospective study
of weight training and risk of type 2 diabetes mellitus in men. Arch Intern Med
2012;172:1306-12.

40.

Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB.
Exercise type and intensity in relation to coronary heart disease in men. JAMA
2002;288:1994-2000.

12

Chapter Two: Review of Literature

13

Insulin Resistance: Definition, History, and Prevalence
Insulin resistance (IR) is characterized by the inability of the body’s tissues to
proper utilize and respond to endogenous insulin(1). Insulin resistance manifests itself in
the body though multiple mechanisms and at different sites. Two examples are: hepatic
IR manifesting itself as impaired fasting glucose (IFG); and peripheral IR manifesting
itself as impaired glucose tolerance (IGT)(2). Both of these states of glucose imbalance
lead to metabolic issues attributable to hyperinsulinemia; which is considered a state of
IR(1).
The idea of insulin insensitivity or “resistance” was first demonstrated in 1936 by
Himsworth(3). It was in this study that the differentiation of insulin-sensitive diabetes
(type 1) and insulin insensitive diabetes (type 2) was determined through specific tests
investigating insulin response to carbohydrates. Furthermore, this study proposed several
possibilities that could contribute to the insulin resistive state: 1) the liver may be pouring
so much sugar into the blood that the effect of the injected insulin is overwhelmed; 2) the
liver may be incapable of storing the ingested sugar; or 3) the characteristic action of
insulin in promoting storage of blood-sugar in the peripheral tissues may be unable to
manifest itself(3). In 1960, Yalow and Berson(4) suggested that insulin sensitivity, and
not deficiency in insulin secretion, could play an important role in the hyperglycemia of
diabetes.
Current prevalence estimates of IR vary depending on definition, site and
measurement of IR(2). In the 1988 Banting lecture, Reaven(5) stated that IR is present in
the majority of patients with IGT or type 2 diabetes and in approximately 25% of nonobese individuals with normal oral glucose tolerance. In a cross-sectional analysis
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conducted by Ioannou et al.(6) prevalence of IR was determined using a representative
sample from the Third National Health and Nutrition Examination Survey (NAHNES III,
1988-1992) and from the 1999-2002 NAHNES with and without diabetes. Insulin
resistance was defined using the homeostatic model assessment of IR (HOMA-IR).
Subjects in the upper quartile of HOMA-IR were characterized as being insulin resistant.
Following adjustment for covariates, the prevalence of IR in subjects from NHANES III
without diabetes or IFG was 26.2% (95% CI 23.6–28.9). Prevalence of IR was
significantly higher in subjects from the 1999-2002 NHANES; 32.2% (95% CI 29.5–
35.0) indicating a significant positive trend in IR among subjects with normoglycemia. In
another cross-sectional analysis conducted by Li et al.(7), investigators sought to
determine specific trends in hyperinsulinemia among U.S. adults without diabetes
utilizing data from NHANES III and the 1999-2002 NHANES. Hyperinsulinemia was
defined as residing in the upper 75th percentile of log-transformed fasting insulin. Across
the entire sample, the mean fasting insulin level was significantly higher (p=0.025) in
subjects from the 1999-2002 NHANES (2.16 ± 0.01) compared to those from NHANES
III (2.12 ± 0.01). Moreover, the age-adjusted prevalence of hyperinsulinemia increased
by 35.1% (25.8% in NHANES III to 34.8% in the 1999-2002 NHANES, p<0.001).
Bonora et al.(8) investigated the prevalence of IR among individual metabolic
disorders in a sample of 888 subjects from the Bruneck study. Insulin resistance was
defined as the lower limit of the top quintile of HOMA-IR distribution. A significant
positive trend was seen across quintiles of IR and prevalence of IGT (p=0.011),
hypercholesterolemia (p<0.001), hypertriglyceridemia (p<0.001), low high-density
lipoprotein cholesterol (HDL-C, p=0.049), and hypertension (p=0.002). The prevalence
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of IR was 65.9% in IGT subjects, 53.5% in subjects with hypercholesterolemia, 84.2% in
subjects with hypertriglyceridemia, 88.1% in subjects with low HDL cholesterol, and
58.0% in hypertensive subjects. Insulin resistance is a complex, multifactorial metabolic
condition that is increasing in prevalence, even in euglycemic subjects. Furthermore, IR
appears to be highly prevalent among several cardio-metabolic risk factors.
Homeostatic model assessment of insulin resistance
History and physiological rationale
In 1985, Matthews et al.(9) created a model known as the HOMA-IR to estimate
both IR and β-cell function. The physiological basis for HOMA-IR utilizes the
relationship between basal concentrations of glucose and insulin, reflecting the action of
the negative feedback-loop between the liver and the β-cells(10). Hepatic IR can be
estimated based on the effects of reduced insulin secretion capacity, leading to increased
hepatic glucose efflux. This increase in basal plasma glucose stimulates increased
secretion of insulin within the portal vein, until glucose levels return to normal: thus the
“feed-back” loop between the liver and β-cells. The basal plasma insulin levels necessary
to maintain normal glucose levels are directly proportional to the grade of IR(10). Based
on these interactions between the liver and β-cells, a nonlinear computer model was
created to allow for assessment of IR and β-cell function(9). This model allows for a
prediction of either IR or β-cell function based solely on a subjects fasting insulin and
basal glucose levels. The following represents the HOMA-IR equation: [fasting serum
insulin (mU/ml) x fasting plasma glucose (mmol/l)]/22.5. It is important to note that
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while HOMA-IR is primarily a reflection of hepatic IR, there is a 70% correlation
between hepatic IR and peripheral IR.(2)
Comparison to other techniques
Values from HOMA-IR have been compared and validated against several other
techniques for assessing IR,(9,11) such as the euglycemic-hyperinsulnemic clamp, the
hyperglycemic clamp, and the continuous infusion of glucose with model assessment
(CIGMA). In the original study conducted by Matthews et al.(9), HOMA-IR was
validated (via the Spearman correlation coefficient test) against several other methods for
assessing IR, both in euglycemic and subjects with diabetes. Strong correlations were
seen between HOMA-IR and the euglycemic hyperinsulinemic clamp in subjects with
(Rs=0.92,p<0.0001) and without diabetes (Rs=0.83,p<0.01), the hyperglycemic clamp in
a combined sample of subjects with and without diabetes (Rs=0.69,p=0.0005), and the
CIGMA method in subjects with (Rs=0.97, p<0.0001) and without (Rs=0.69,p<0.02)
diabetes. Bonora et al.(12) compared insulin sensitivity, assessed by a four hour
euglycemic and hyperinsulinemic clamp, to HOMA-IR in 115 subjects with varying level
of insulin sensitivity and glucose tolerance. Sixty-two subjects had diagnosed diabetes
and 53 subjects were without diabetes. Results showed strong correlations between
clamp-measured total glucose disposal and HOMA-IR (r=0.820, p<0.0001). Furthermore,
strong correlations were seen between clamp measurements and HOMA-IR in men
(r=0.800), women (r=0.796), younger (aged 50 years, r=0.832) and older (r=0.800)
subjects, non-obese (BMI<27 kg/m2, r=0.800) and obese (r=0.765) subjects, subjects with
(r=0.754) and without (r=0.695) diabetes, and normotensive (r=0.786) and hypertensive
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(r=0.762) subjects. In 87 subjects with NGT, García-Estévez et al.(13) revealed a
significant correlation (r=0.70, p=0.001) between HOMA-IR and CIGMA.
HOMA-IR Uses (Cross-sectional and Prospective)
HOMA-IR has been utilized as a measure of IR in over 500 published
articles(11). Furthermore, greater than 50% of those articles have utilized the model in
subjects without diabetes(11). Many cross-sectional studies have utilized HOMA-IR as a
measurement of IR(14-16). Ausk et al.(14) revealed a significant relationship between
all-cause and CVD mortality across quartiles of HOMA-IR in subjects without diabetes.
Healy et al.(15) investigated the associations between increasing levels of sedentary time
and cardio-metabolic risk in a sample of 4,757 adults (≥20 years) from the 2003-2006
NHANES. Results revealed a significant positive trend across quartiles of total sedentary
time and HOMA-IR (p<0.001). Haffner et al.(16) investigated the correlations between
HOMA-IR and fasting insulin in a cross-sectional analysis of 2,465 subjects from the San
Antonio Heart Study. Results revealed a significant correlation between HOMA-IR and
fasting insulin in subjects with (r=0.908) and without (r= 0.991) diabetes. Utilizing data
from the NHANES III, Durward et al.(17) investigated the risk of mortality across
varying definitions of metabolic health. Metabolically healthy was defined as either: 1)
HOMA-IR <2.5; 2) ≤2 Adult Treatment Panel (ATP) III metabolic syndrome criteria; 3)
combined definition using ≤1 of the following: HOMA-IR ≥1.95 (or diabetes
medications), triglycerides ≥1.7 mmol/L, HDL-C <1.04 mmol/L (males) or <1.30
mmol/L (females), LDL-C ≥2.6 mmol/L, and total cholesterol ≥5.2 mmol/L (or
cholesterol-lowering medications). Subjects considered metabolically unhealthy based on
the HOMA-IR definition had a significantly greater hazard ratio for all-cause mortality
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(2.07, p<0.01) compared to those who were considered metabolically healthy by HOMAIR definition.
HOMA-IR has also been used as a measure of IR in many prospective studies(1820). Bonora et al.(18) investigated the incidence rates and risk factors for type 2 diabetes
in cohort of white individuals who participated in the Bruneck Study. Results revealed
that subjects in the highest quartile of HOMA-IR had significantly higher odds of
developing type 2 diabetes (OR 8.5, p<0.001). Furthermore, it was revealed that every
one-standard deviation increase in HOMA-IR coincided with increased odds for
developing type 2 diabetes (OR 1.7, p< 0.018). Another study conducted by Bonora et
al.(20) revealed that a one-unit increase in HOMA-IR was associated with an increased
odds for incident CVD during (OR 1.56, p<0.001) in subjects with type 2 diabetes. Sung
et al.(19) investigated the relationship between HOMA-IR and incident hypertension in a
sample of euglycemic, normotensive Korean adults (n= 10,894). Results revealed a
significant trend across quartiles of HOMA-IR and incident hypertension after five years
of follow-up (p<0.01). Furthermore, subjects in the third (OR 1.5, p<0.05) and fourth
(OR 1.7, p<0.05) quartiles of HOMA-IR had significantly higher odds of developing
hypertension compared to those in the first quartile.
Misuses of HOMA-IR
The use of HOMA-IR as a measure of IR is not appropriate for all assessments
and study designs. The use of HOMA-IR in animal studies has not been validated and
also violates some physiological assumptions made by the model(11). HOMA-IR also
cannot be used to report β-cell function in isolation(11). Due to the relationship between
β-cell secretion rate and insulin sensitivity it is possible to misinterpret the results of the
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model as issues with β-cell function when in actuality it is attributable to high insulin
sensitivity and not failing β-cells(11). An example of this is using HOMA-IR as a
measure of IR in a fit athlete with 50% β-cell function and 200% insulin sensitivity. A
subject with 50% β-cell function would intuitively be considered to have failing β-cells.
However, the attenuated β-cell function is attributable to high levels of insulin sensitivity
and not complications with β-cells(11). Thus, this means using HOMA-IR in one subject,
specifically in a highly insulin sensitive subject, would elicit a possible misinterpretation
of the function of their β-cells.
Muscular strengthening activities
Muscular strengthening activities (MSA) are exercise modalities that have been
shown to help play a role in the prevention and management of multiple chronic diseases
and metabolic risk factors. Currently the Department of Health and Human Services
(DHHS) recommends participation in MSA at moderate or high intensity; involving all
major muscle groups (the legs, hips, back, chest, abdomen, shoulders, and arms) ≥2
days/week(21). The DHHS defines MSA as participation in activities that overload the
muscles. These include: resistance training (RT), such as weight training, working with
resistance bands, doing calisthenics utilizing body weight for resistance (such as pushups, pull-ups, and sit-ups), carrying heavy loads, or heavy gardening (such as digging or
hoeing)(21).
The current prevalence estimates of MSA participation ranges from
approximately 6%-31.7%(22-25). Utilizing data from the 2009 Health Styles survey,
Loustalot et al.(25) reported that 31.7% of respondents reported participation in MSA ≥2
days/week. However, only 6.0% of respondents reported adequate MSA including all
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seven major muscle groups. The Centers for Disease Control (CDC) examined the
prevalence of meeting the DHHS MSA recommendations using data from the 1998-2004
National Health Interview Survey (NHIS)(24). Results revealed a prevalence of 19.4%
(95% CI 19.0-20.3) in 2004. Using data from the 1998-2008 NHIS, Carlson et al.(22)
reported a 21.9% (95% CI 21.2-22.7) prevalence of adequate MSA participation in 2008.
The most recent estimates for MSA participation were reported by the CDC using data
from the 2011 Behavior Risk Factor Surveillance Survey (BRFSS)(23). Analysis
revealed a prevalence estimate of 29.3%. Based on these data it is estimated that the
prevalence of meeting the DHHS MSA recommendations is approximately 20-30%.
Relationship to insulin resistance/glycemic control
Several studies have revealed significant inverse associations between IR and
MSA in subjects that are euglycemic(26-31). Ahmadizad et al.(26) investigated the
effect of resistance or endurance training on IR in 24 healthy males (35–48 years). Study
subjects had no medical condition that would inhibit exercise participation. Furthermore,
subjects had not participated in regular exercise for at least 12 months. Subjects were
randomly assigned to one of three groups: endurance training group (n=8), RT group
(n=8) or control group (n=8). Insulin resistance was assessed via HOMA-IR. Following
intervention, significant reductions in IR were seen in both the resistance (38.5%, p<0.05)
and endurance training groups (35.7%, p<0.05). No significant differences were seen
between exercise intervention groups.
In a cross-sectional analysis conducted by Cheng et al.(27), investigators
examined the associations between MSA and insulin sensitivity (measured via the
qualitative insulin sensitivity check index [QUICKI](32)), fasting insulin, and fasting
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glucose. Subjects (n=4,504) participated in the 1999-2004 NHANES and did not have
diabetes. Muscular strengthening activity was divided into three categories: low (<1
day/week), moderate (1–2.9), or high (≥3). Following adjustment for covariates, women
reporting moderate (p=0.025) or high (p=0.021) amounts of MSA had significantly
higher QUICKI levels compared to those reporting low levels of MSA. Furthermore,
women reporting high levels of MSA had significantly lowered fasting insulin levels (p=
0.007) compared to those reporting low amounts of MSA. In men, only those reporting
high levels of MSA had significantly higher QUICKI levels (p=0.003) and significantly
lowered fasting insulin levels (p=0.007) compared to those reporting low MSA levels.
Miller et al.(28) investigated the effects of a 10-week isotonic RT program on
glucose tolerance, fasting insulin and the insulin response to an OGTT. College-aged
subjects without diabetes were used. Following intervention, significant changes were
seen in basal plasma insulin levels (37.5%, p<0.05), indicating significant decreases in
IR. Moreover, the insulin response to a 100-g OGTT was significantly reduced (18.0%
p<0.05), further illustrating significant reductions in IR. In another trial, Miller et al.(29)
investigated the effects of a 16-week RT intervention on IR in 11 healthy men (50-63
years). Insulin resistance and action was assessed via a two-step hyperinsulinemiceuglycemic glucose clamp and an OGTT. Following the RT intervention, there were
significant decreases in both fasting plasma insulin levels (p<0.05) and insulin levels in
response to an OGTT (p<0.05). Glucose infusion rates during the hyperinsulinemiceuglycemic glucose clamp increased 24% (p<0.05) during low insulin infusion and
increased 22% (p<0.05) during high insulin infusion; indicating increases in peripheral
insulin sensitivity.
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Craig et al.(30) investigated the insulin response to an OGTT following a 12week RT intervention in six younger (23 ± 1 year) and nine older (63 ± 1 year) subjects.
Insulin response to an OGTT was significantly reduced in both groups (p<0.05). The sum
insulin response to an OGTT decreased by 31.8% in the younger group and decreased by
32.6% in the elderly group, indicating reductions in peripheral IR. Kodama et al.(31)
investigated the effects of low-intensity and low-volume exercise training on IR in
elderly subjects. Subjects (n=56, 64±6 years), participated in a 12-week exercise
intervention that included aerobic and RT. Results revealed a significant reduction in IR
(21%, p<0.05), independent of BMI changes.
In a cross-sectional analysis conducted by Churilla et al.(33), investigators sought
to determine the associations between meeting the current DHHS MSA recommendations
and components of metabolic syndrome. Subjects (n=5,618, ≥20 years) participated in the
1999-2004 NHANES. Metabolic syndrome was defined using the American Heart
Association/ National Heart, Lung, and Blood Institute cut-points. Following adjustment
for potential confounding, subjects reporting meeting the DHHS MSA recommendations
had lower odds of having IFG (OR 0.71, p<0.05) compared to subjects reporting no
MSA. Furthermore, the prevalence of IFG was significantly lower in subjects meeting the
DHHS MSA recommendations (28.3%, 95% CI 24.8-32.1) compared to those reporting
no MSA (38.0%, 95% CI 35.2-40.9).
Relationship to lean body mass and insulin resistance
Intuitively, routine participation in sufficient amounts of MSA will lead to
increases in lean body mass (LBM). Several studies have shown inverse associations
between LBM and IR(28,34). Miller et al.(28) investigated the effects of a 10-week
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isotonic RT on insulin response to and OGTT and basal insulin levels in college aged
men without diabetes. A significant increase in LBM (3.5%, p<0.05) was seen following
intervention. Furthermore, the increase in LBM was highly correlated with the reductions
in insulin in response to an OGTT (r = -0.89, p<0.05). In a study using NHANES III,
Srikanthan et al.(34) investigated the associations between skeletal muscle index (SMI, a
measure of LBM) and IR in subjects with and without diabetes. Insulin resistance was
investigated using HOMA-IR. Skeletal muscle index was categorized into quartiles.
Following adjustment for covariates, results revealed a significant inverse dose-response
relationship between quartiles of SMI and IR (p<0.0001). After exclusion of subjects
with diabetes, the results remained significant (p<0.0001). Furthermore, results revealed
that for every 10% increment increase in SMI, there was a 14% reduction in HOMA-IR
in subjects without diabetes.
Relationship between muscular strength and insulin resistance
Some studies have shown an inverse association between IR and muscular
strength, a physiological adaptation to MSA(35,36). Barzilay et al.(35) investigated the
associations between quadriceps muscle strength and IR. Subjects (n= 2,006, ≥70 years)
were without diabetes and were considered to be well-functioning (self-reported no
difficulty with walking one-quarter mile or walking up 10 steps without stopping).
Insulin resistance was measured via HOMA-IR. A significant inverse association was
seen between strength per kilogram of muscle mass and IR in white and black males and
females (p<0.001). A significant inverse association was also seen between quadriceps
muscle mass and IR (p<0.001).
Karelis et al.(36) examined the associations between a muscular strength index
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(MSI, calculated by dividing the subject’s leg press 1-RM and LBM in kg) and insulin
sensitivity in a cohort of obese and overweight postmenopausal women. Study subjects
(n=82) were diabetes-free. Insulin resistance was assessed via the hyperinsulinemiceuglycemic glucose clamp. The MSI was categorized into quartiles. Following covariate
adjustment, a significant positive association was seen between MSI and insulin
sensitivity (r=0.37, p<0.001). Furthermore, subjects in the highest quartile of MSI had
higher levels of insulin sensitivity (p<0.05) compared to those in the first and second
quartiles.
Postulated mechanisms
There are several postulated mechanisms by which muscle contraction, and acute
and chronic participation in exercise may play a role in the reduction of IR or the
prevention of reaching an insulin resistive state(37-41). Several studies and reviews have
discussed the effect of muscle contraction and exercise as a whole on IR. These
mechanisms include: increased insulin sensitivity attributable to the effect of exercise on
Glut4 expression and activation, the effect of exercise on glycogen synthase, effects on
muscle fiber type, calcium levels, and increases in LBM.
Muscle contraction has been shown to lead to increases in tissue permeability and
sensitivity to glucose(38). More specifically, several studies have revealed that both acute
and chronic participation in exercise leads to an increase in insulin sensitivity via effects
on Glut4 expression and activation(37,39,41-43). Glut4 plays a primary role in the uptake
of glucose into tissue for use as fuel or for storage(37). The specific cellular mechanisms
in which muscle contraction effects Glut4 activation and expression are not fully
understood(37) but advances in microscopy techniques have given further insight into
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these mechanisms(44). In a study conducted by Gjovaag et al.(39), investigators reported
significant increases in Glut4 concentration (p<0.01) in the triceps brachii following a
five to eight week strength protocol. Furthermore, Glut4 concentration was higher
(p<0.01) in subjects participating in high loading (60% 1-RM) compared to lower loading
(30% 1-RM); suggesting higher intensity training leads to increased exercise stimulated
glucose uptake. Goodyear et al.(43) reported significant increases in the number of
glucose transporters following electrically stimulated muscle contractions in the
hindquarters of male rats. Exercise has been shown to stimulate the increase in the
activity of glycogen synthase, an enzyme that stimulates the synthesis of glycogen from
glucose-6-phosphate, following exercise(42). This increase in enzyme concentration is
attributable to increased permeability of muscle tissue and increased expression of
Glut4(42).
Routine participation in RT has been shown to increase the number of type IIa
(fast twitch red) fibers(45,46). In earlier research, Ivy et al.(38) revealed that insulin
sensitivity is increased in both fast and slow twitch red fiber types. Similarly, Richter et
al.(47) revealed the highest insulin sensitivity to be fast twitch red fibers and the lowest
being fast twitch white fibers(47). This is due primarily to the high glycolytic and
oxidative capacity of the fast twitch red fiber types(38). More recently, Mackrell et
al.(48) revealed a two-fold increase in insulin-mediated glucose uptake in myosin heavy
chain (MyHC) IIa fibers in rats compared to MyHC IIx fibers. Gjovaag et al.(39)
investigated the effects of RT on the conversion of MyHC IIx fibers to MyHC IIa.
Results revealed significant increases in MyHC IIa fibers (p<0.05) as well as significant
decreases in MyHC IIx fibers (p<0.05). Furthermore, a significant positive correlation

26

(r=0.73, p<0.01) was found between increases in MyHC IIa fibers and Glut4
concentration.
Calcium may also contribute to the increases in insulin sensitivity due to
exercise(37,38). Youn et al.(49) revealed calcium to stimulate glucose transport
independent of muscle contraction. However, Goodyear et al.(37) noted that this
activation of glucose transport is most likely not a direct effect of calcium but attributable
to the activation of Protein Kinase C. Protein Kinase C is a calcium-dependent signaling
kinase that could contribute to the regulation of contraction-stimulated glucose
transport(37). Miller et al.(28) revealed a strong inverse association (r=-0.89, p<0.05)
between insulin response to an OGTT and LBM in subjects without diabetes. This is
indicative of a decrease in peripheral IR. One possible explanation is an increase in the
clearance of insulin attributable to the increase in insulin sensitive tissues. Due to the rate
of clearance for insulin being directly proportional to its binding capacity(50), an increase
in availability of binding sites could potentially lead to increased sensitivity. The
increases in LBM may also contribute to decreased IR due to increased area for glycogen
storage(28).
Summary
It is evident in the literature that IR is highly prevalent even in subjects without
diabetes: approximately one-fourth to one-third depending upon the specific study(5-7).
Furthermore, research has shown that the prevalence of IR in euglycemic subjects is
following a positive trend(7). Insulin resistance is also highly prevalent among
individuals with various metabolic health conditions(8). HOMA-IR has been shown to be
a validated method of assessing IR in euglycemic subjects in both cross-sectional and
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prospective subjects. It has also been shown to have a strong correlation with peripheral
insulin sensitivity thus allowing for its use as a proxy measure for studies specifically
investigating peripheral IR(2). Moreover, over 50% of studies utilizing the HOMA-IR
method have investigated subjects without diabetes(11).
In the 11 studies identified in the literature investigating the association between
MSA and IR, all have consistently shown an inverse relationship with participation in
adequate volumes of MSA and IR levels in euglycemic subjects. Furthermore, studies
have shown that physiological adaptations due to MSA participation (increases in LBM
and increases in muscular strength) are inversely associated with IR. Many mechanisms
have been proposed and investigated as to why these favorable associations are seen;
however they are not fully understood. Nonetheless, it is evident that there is a significant
inverse relationship between MSA and IR, even in euglycemic subjects.
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Data Collection
Data were obtained utilizing the National Health and Nutrition Examination
Survey (NHANES). The NHANES is conducted by the National Center for Health
Statistics (NCHS) and is a continuous survey that regularly releases public-use data
files(1). Originally introduced in the 1960’s, the NHANES began as a series of surveys
focusing on select populations and health outcomes. There are five series that have been
conducted. NHANES I began in 1971 and ended in 1974. NHANES II began in 1976
and ended in 1980. NHANES III (phase 1) began in 1988 and continued through 1991.
NHANES III (phase 2) began in 1991 and finished in 1994. In 1999, NHANES became a
continuous survey, producing data sets in two-year cycles. The continuous NHANES
changed its focus to a variety of health and nutrition measurements with respect to
emerging disease and adverse health conditions. The NHANES is cross-sectional in
nature and is characterized by a complex, multi-stage sampling design in order to obtain a
representative sample of the U.S. population(2). The sampling technique is divided into
four distinct stages to obtain a representative sample of the non-institutionalized U.S.
population aged two months and older living in households(2). During stage 1 specific
primary sampling units (PSUs) are selected. These are mostly single counties or, in a few
cases, groups of contiguous counties with probability proportional to a measure of size
(PPS). Stage 2 is characterized by the division of the PSUs into segments (generally city
blocks or their equivalent). Like the PSUs, these segments are divided with PPS. Stage 3
is characterized by households within each segment being listed, and a sample is
randomly drawn. In geographic areas where the proportion of groups selected for
oversampling is high, the probability of selection for those groups is greater than in other
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areas. In stage 4 individuals are chosen to participate in NHANES from a list of all
persons residing in selected households. Individuals are drawn at random within
designated age-sex-race/ethnicity screening subdomains(2).
A component of the NHANES is oversampling of specific demographics and
characteristics of the population. The purpose for this technique is to ensure an adequate
representation of certain minority groups (subjects) as well as increasing the reliability
and precision estimates for these specific groups(2). Examples of oversampled subgroups
in the 1999-2004 NHANES include: African Americans, Mexican Americans, families
with low income, adolescents aged 12-19 years, and persons age ≥60 years.
The NHANES was designed to provide national estimates of the health and
nutritional status of non-institutionalized U.S. civilians two months of age and older
through both objective (examination) and subjective (interview) measures(1). The
NHANES assesses demographic, socioeconomic, dietary and health-related aspects of
life through interview. The examination takes place at a mobile examination center
(MEC) where both physiological measurements and laboratory tests are administered by
trained medical personnel(1).
Subjects
The total 1999-2004 NHANES sample N was 31,126. Of those, 15,332 subjects
were ≥20 years of age, the population of interest for this study. We excluded 833 women
who reported being pregnant, and 8,781 subjects who were non-fasted. Subjects with
diabetes (n=617) or pre-diabetes (n=833) were excluded from the study as well.
Following exclusion of those with missing data (n=1,640) for any variable included in the
analysis, 2,543 remained in our analysis as eligible study subjects. The final sample met
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the following conditions: 1) adult men and women ≥20 years of age; 2) attended a
morning MEC following an overnight fast; 3) if female, non-pregnant; 4) had complete
data on all the variables of interest and 5) were without diabetes (glycosylated
hemoglobin <5.7%, and answered no to the question DIQ010: (Other than during
pregnancy, have you ever been told by a doctor or health care professional that you have
diabetes or sugar diabetes?).
Measures
Dependent Variable: Muscular Strengthening Activity
Current recommendations set forth by the Department of Health and Human
Services (DHHS) state that the healthy population should participate in MSA two or
more days per week(3). The dependent variable in this study was calculated from ‘selfreported’ MSA patterns. The final sample provided responses to the following items,
which came from the PA questionnaire file item PAD440: "Over the past 30 days, did
you do any physical activities specifically designed to strengthen your muscles such as
lifting weights, push-ups or sit-ups?) Include all such activities even if you have
mentioned them before in the past 12 months." No self-reported MSA was used as the
dependent variable in this study.
Independent Variable: HOMA-IR
The primary independent variable was IR. We used the homeostatic model
assessment of insulin resistance (HOMA-IR) as a measure for IR, calculated via the
equation by Matthews et al.(4): [fasting serum insulin (mU/ml) x fasting plasma glucose
(mmol/l) /22.5]. Age-adjusted quartiles of log-transformed HOMA-IR were created using
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every 25th percentile based on weights specific to NHANES: Q1 (<0.20), Q2 (≥0.20 and
<0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55). HOMA-IR was log transformed due to the
the data not being normally distributed following a test for normality.
Other independent variables:
Other independent variables or potential mediating factors include age, gender,
race/ethnicity, education, smoking, alcohol, waist circumference, and non-MSA specific
leisure-time physical activity (LTPA).
Age:
Five categories of age were created: 20-29, 30-39, 40-49, 50-59 and ≥60.
Gender:
Gender was dichotomized as male or female.
Race/Ethnicity:
Four categories of race were created: non-Hispanic White, non-Hispanic Black,
Mexican American and Other.
Education:
Education was categorized into four groups: less than high school, high school
graduate, some college, and college graduate.
Smoking:
Three categories of smoking were created: current smoker, former smoker (quit
within last six months), and non-smoker.
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Alcohol:
Three categories of alcohol consumption were created based on the United States
Department of Agriculture (USDA) and DHHS gender specific cut-points(5): non-drinker
(0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above
moderate (>1 [women], >2 [men] drinks/day).
Waist circumference:
Waist circumference (WC) was used as a measure for adiposity and dichotomized
by gender specific cut-points(6): men (elevated: ≥102cm, desirable <102cm), women
(elevated: ≥88cm, desirable <88cm).
Non-MSA specific Leisure-time physical activity
Leisure time physical activity was categorized into three levels based on the 2008
DHHS PA guidelines(3): none (0 min/week), insufficient (1-149 min/week) and meeting
the recommendations (≥150 min/week). The LTPA variable was created from a
compendium of activities within the 1999-2004 NHANES. These activities are primarily
aerobic activities. However, some activities, such as rock climbing or wrestling
incorporate both anaerobic (resistance) and aerobic pathways. Within the NHANES,
MSA is defined exclusively using the PAD440 question. The LTPA variable used in this
study is mutually exclusive of the PAD440 question and has been used as a measure of
aerobic PA in several studies(7,8).
Data Analysis
The NHANES data are weighted to account for the complex survey design,
oversampling, survey non-response, and post-stratification to match 2000 U.S. Census
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population control totals. Subjects participating in the NHANES are assigned a weight
that is equivalent to the reciprocal of their probability of selection. Due to the complex
survey design, these base weights must be calculated utilizing the reciprocal of their final
probability of selection. The final probability incorporates the following: the probability
of the PSU being selected; the probability of a segment of the PSU being selected;
probability of a household being selected; and the probability of an individual being
selected. Base weights are also adjusted for non-response to the in-home interview when
creating interview weights. They are further adjusted for non-response to the MEC exam
when creating exam weights(9).
Compared to earlier NHANES cycles, the sample size in the two-year continuous
cycle is smaller. Thus the use of a statistical software program, capable of handling the
increased sampling variation is necessary. SAS-callable SUDAAN(12) was used to
handle to complex survey design and create an unbiased estimate of the variance(10).
Statistical Analysis
The data in this study were initially managed using SAS 9.2(11). SAS was used to
conduct both complex variable recodes and validation of data coding. SAS-callable
SUDAAN(12) was then used to conduct the analysis, incorporating sampling weights
within the context of the correlated multi-stage complex sampling design inherent to
NHANES. Age-adjusted prevalence estimates were calculated using PROC DESCRIPT.
Non-overlapping 95% confidence intervals (CI) with coinciding p-values illustrate
significance (p<0.05). Logistic regression (PROC RLOGIST) analysis was used to test
the null hypotheses that individual regression coefficients are equal to zero for each
quartile of HOMA-IR. The three logistic regression models created included the primary
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independent variable HOMA-IR unadjusted; a second model adjusting for age, race,
gender, education, smoking, alcohol consumption, WC and HOMA-IR; and a third model
further adjusting for LTPA.
Limitations
Aspects of the 1999-2004 NHANES may limit the findings of this study. A
portion of this survey is based on self-reported data. These self-reported variables are
subject to recall bias. Furthermore, the self-reported data is subject to social-desirability
bias (a response provided to please the interviewer). The nature of the survey can be
subject to interview bias. Due to the cross-sectional study design, causality cannot be
established between variables. Measurement errors, coding errors, and sampling errors
may also occur in survey designs. The final limitation is residual confounding, which is
inherent to all survey research.
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Chapter Four: The Associations between HOMA-IR and Muscular Strengthening
Activity in euglycemic U.S. Adults
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Background: Muscular strengthening activity (MSA) has been shown to be inversely
associated with insulin resistance (IR). We examined the associations between quartiles
of the homeostatic model assessment of insulin resistance (HOMA-IR) and self-reported
MSA in a nationally representative sample of euglycemic U.S. adults.
Methods: Sample included adult participants (≥20 years of age [n=2,543]) from the
1999-2004 National Health and Nutrition Examination Survey (NHANES). HOMA-IR
was categorized into quartiles based on every 25th percentile. No self-reported MSA was
the dependent variable.
Results: Following adjustment for covariates, those with HOMA-IR values in third
(p<0.01) and fourth (p<0.001) quartiles were found to have significantly greater odds of
reporting no MSA. Following further adjustment for non-MSA specific leisure time
physical activity, results remained significant (p<0.05 third, p<0.001 fourth). A
significant positive trend was seen across quartiles of HOMA-IR (p=0.01) for odds of
reporting no MSA.
Conclusions: Having a higher HOMA-IR value is associated with greater odds of
reporting no MSA in euglycemic U.S. adults.
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The homeostatic model for insulin resistance (HOMA-IR) has been extensively
used as a measure for insulin resistance (IR) in epidemiological studies. Greater levels of
IR have been shown to be highly associated with incidence of type 2 diabetes(1,2) and
cardiovascular disease (CVD)(3-6). Interestingly, previous studies using surveillance
data have also estimated that HOMA derived IR(7) and hyperinsulinemia(8) are highly
prevalent in subjects who are apparently healthy.
Traditionally, muscular strengthening activity (MSA) has been examined as an
independent predictor of IR in subjects without diabetes. Several studies have
investigated these associations(9-16). Miller et al.(9) reported a significant reduction
(37.5%, p<0.05) in basal insulin levels and insulin levels in response to an oral glucose
tolerance test (OGTT) (p<0.05) in eight young healthy male subjects following a 10week high-resistance, isotonic weight-lifting program. Cheng et al.(13) investigated the
associations between volumes of MSA and IR, measured via the quantitative insulin
sensitivity check index (QUICKI), in subjects without diabetes utilizing data from the
1999-2004 National Health and Nutrition Examination Survey (NHANES). Results
revealed significantly higher QUICKI levels in subjects reporting ≥1 day/week of MSA
(p<0.05). Following adjustment for covariates, results remained significant in females but
not males. Significance was only seen in volumes of MSA ≥3 days/week (p<0.05) in
males.
Currently, no studies have examined these associations using HOMA-IR as the
independent variable. This novel approach, defined as using a disease or adverse
metabolic condition as the independent variable and physical activity (PA) as the
dependent varibale, has been used in few studies(17-21). Moreover, this approach allows
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for a clinical interpretation of surevillance data, providing potential insight into PA
patterns in diseased subjects. The purpose of this study was to invesitgate the
associations between quartiles of HOMA-IR and self-reported MSA in a representative
sample of euglycemic adults in the United States (U.S.). To the extent of our knowledge,
this is the first study to examine the assocations between quartiles of HOMA-IR and
MSA in a representative sample of euglycemic U.S. adults.
Methods
This study utilized six years of data from the 1999-2004 NHANES, a continuous
survey conducted by the National Center for Health Statistics(22). The NHANES was
designed to provide national estimates of the health and nutritional status of noninstitutionalized U.S. civilians over the age of two months. The total 1999-2004
NHANES sample N was 31,126, ages two months and above. Out of the 15,332 subjects
(≥20 years of age) who participated in the 1999-2004 NHANES, we excluded 833
women who reported being pregnant, and 8,781 subjects who were non-fasted. Subjects
with diabetes (n=617) or pre-diabetes (n=833) were excluded from the study as well.
Following exclusion of those with missing data (n=1,640) for any variable included in the
analysis, 2,543 remained in our analysis as eligible study subjects. The final sample met
the following conditions: 1) adult men and women ≥20 years of age; 2) attended a
morning medical exam in a mobile examination center following an overnight fast; 3) if
female, non-pregnant; 4) had complete data on all the variables of interest and 5) were
without diabetes (glycosylated hemoglobin <5.7%, and answered no to the question
DIQ010: (Other than during pregnancy, have you ever been told by a doctor or health
care professional that you have diabetes or sugar diabetes?).

49

Muscle Strengthening Activity
Current recommendations set forth by the Department of Health and Human
Services (DHHS) state that the healthy population should participate in MSA two or
more days per week(23). The dependent variable in this study was calculated from ‘selfreported’ MSA. The final sample provided responses to the following items which came
from the physical activity (PA) questionnaire file item PAD440: Over the past 30 days,
did you do any physical activities specifically designed to strengthen your muscles such
as lifting weights, push-ups or sit-ups? Include all such activities even if you have
mentioned them before in the past 12 months. No self-reported MSA was used as the
dependent variable in this study.
Insulin Resistance
The independent variable was IR. We used the HOMA-IR as a measure for IR;
calculated via the equation by Matthews et al.(24): [fasting serum insulin (mU/ml) x
fasting plasma glucose (mmol/l)]/22.5. Age-adjusted log-transformed quartiles of
HOMA-IR were created using every 25th percentile based on weights specific to
NHANES: Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and ≤0.55) and Q4 (>0.55).
Covariates
Five categories of age were created: 20-29, 30-39, 40-49, 50-59 and ≥60. Four
categories of race were created: non-Hispanic White, non-Hispanic Black, Mexican
American and Other. Education was categorized into four groups: less than high school,
high school graduate or GED, some college, and college graduate. Three categories of
smoking were created: smoker, former smoker (quit within last six months), and non-
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smoker. Three categories of alcohol consumption were created based on the United States
Department of Agriculture and DHHS gender specific cut-points: non-drinker (0
drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above
moderate (>1 [women], >2 [men] drinks/day)(25). Waist circumference (WC) was used
as a measure for adiposity and dichotomized by gender specific cut-points: men
(elevated: ≥102cm, desirable <102cm), women (elevated: ≥88cm, desirable <88cm)(26).
Leisure time physical activity (LTPA) was categorized into three levels: 0 min/week, >0
to <150 min/week, and meeting the 2008 DHHS PA recommendations ≥150
min/week(23).
Statistical Analysis
The data in this study were initially managed using SAS 9.2(27) which was used
to conduct both complex variable recodes and data coding validation. SAS-callable
SUDAAN(28) was then used to conduct the analysis, incorporating sampling weights
within the context of the correlated multi-stage complex sampling design inherent to
NHANES. Age-adjusted prevalence estimates were calculated using PROC DESCRIPT.
Non-overlapping 95% confidence intervals (CI) with coinciding p-values illustrate
significance (p<0.05). Logistic regression (PROC RLOGIST) analysis was used to test
the null hypotheses that individual regression coefficients are equal to zero for each
quartile of HOMA-IR. The three logistic regression models created included the primary
independent variable HOMA-IR unadjusted, a second model adjusting for age, race,
gender, education, smoking, alcohol consumption, WC and HOMA-IR, and a third model
further adjusting for other non MSA specific LTPA.
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Results
Following adjustment for covariates, those with HOMA-IR values in third
(p<0.01) and fourth (p<0.001) quartiles were found to have significantly greater odds of
reporting no MSA. Following further adjustment for non-MSA specific LTPA, results
remained significant (p<0.05 third, p<0.001 fourth). A significant positive trend was seen
across quartiles of HOMA-IR (p=0.01) for odds of reporting no MSA.
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Table 1 provides a summary of the study sample characteristics.
Table 1. Characteristics of study sample: 1999-2004 NHANES
Covariates

N

Weighted %
(SE)

Q1
Q2
Q3
Q4

731
711
618
483

31.60 (1.41)
28.25 (0.97)
23.48 (1.08)
16.66 (0.99)

20-29
30-39
40-49
50-59
≥60

512
506
505
341
679

22.18 (1.89)
23.91 (1.37)
20.18 (1.08)
15.32 (0.94)
16.31 (1.04)

Male
Female

1281
1262

48.87 (0.88)
51.13 (0.88)

Non-Hispanic White
Non-Hispanic Black
Mexican American
Other

1391
400
596
156

75.99 (2.05)
8.91 (1.18)
6.85 (0.92)
8.25 (1.59)

College graduate
Some college
High school/GED
< High school

520
703
580
740

25.37 (1.64)
30.26 (1.14)
25.93 (1.54)
18.44 (0.91)

1309
639
595

49.95 (1.89)
24.90 (1.35)
25.16 (1.51)

221
1610
712

9.88 (1.05)
65.73 (2.29)
24.38 (2.31)

1446
1097

59.77 (1.09)
40.23 (1.09)

819
723
1001

36.57 (2.08)
30.68 (1.69)
32.75 (1.57)

HOMA-IR

Age

Gender

Race

Education

Smoking
Non-smoker
Former smoker
Smoker
Alcohol consumption
Above Moderate
Moderate
None
WC
Desirable
Elevated
LTPA
Meets Recommendations
Some
None

Table 1. Waist circumference: Men (elevated: ≥102cm, normal <102cm), Women (elevated:
≥88cm, normal <88cm). LTPA: None, Some (≥1 but <150 minutes/week.), Meets
recommendations (≥150 minutes/week.) Q: Quartile; WC: Waist Circumference; MSA: Muscular
strengthening activity; LTPA: Leisure-time physical activity.
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Table 2 provides prevalence estimates for reporting no self-reported MSA. The
prevalence of reporting no MSA was significantly higher in subjects in the third (76.02%,
95% confidence interval [CI] 71.06-80.36) and fourth (81.19%, 95% CI 76.56-85.09)
quartiles of HOMA-IR compared to those in the first (63.64%, 95% CI 58.69-68.31). No
significant differences were found for prevalence of no MSA in the second quartile of
HOMA-IR compared to the first.
Table 3 illustrates the results of the logistic regression analysis of the associations
between quartiles of HOMA-IR and no self-reported MSA in people without diabetes.
The unadjusted odds of reporting no self-reported MSA were significantly greater in
subjects in the third (Odds ratio [OR] 1.90, 95% CI 1.48-2.45) and fourth (OR 2.69, 95%
CI 1.96-3.71) quartiles of HOMA-IR compared to those in the first. Following
adjustment for age, gender, race, education, smoking status, alcohol consumption, and
WC, results remained significant for the third (OR 1.59, 95% CI 1.13-2.23) and fourth
(OR 2.00, 95% CI 1.37-2.91) quartiles. In the fully adjusted model, which included other
non MSA specific LTPA, significance remained for the third (OR 1.51, 95% CI 1.072.14) and fourth (OR 2.10, 95% CI 1.43-3.08) quartiles.
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Table 2. Prevalence estimates for subjects reporting no MSA - 1999-2004 NHANES.
Covariates
HOMA-IR
Q1
Q2
Q3
Q4
Age
20-29
30-39
40-49
50-59
≥60
Gender
Male
Female
Race
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other
Education
College graduate
Some college
High school/GED
< High school
Smoking
Non-smoker
Former smoker
Smoker
Alcohol
Above Moderate
Moderate
None
WC
Desirable
Elevated
LTPA
Meets
Some
None

Prevalence

95% CI

p-for-trend

63.64
68.52
76.02
81.19

58.69-68.31
63.54-73.11
71.06-80.36
76.56-85.09

p<0.001

56.84
66.55
71.85
73.28
83.45

51.76-61.78
60.60-72.01
65.59-77.37
67.77-78.16
78.30-87.57

p<0.001

67.77
73.87

63.99-71.33
70.71-77.27

p<0.001

69.27
67.37
80.75
80.71

65.70--72.62
61.08-73.10
77.26-83.82
74.41-85.75

p<0.05

56.90
68.54
78.40
84.47

51.81-61.85
64.65-72.18
74.12-82.14
80.09-88.03

p<0.001

67.37
71.14
79.45

63.63-70.90
64.14-77.26
75.83-82.65

p<0.001

67.34
67.49
80.80

60.57-73.45
64.36-70.47
76.57-84.43

p<0.001

65.12
79.45

61.54-68.55
76.29-82.28

p<0.001

46.17
75.66
90.08

46.17-53.73
71.27-79.57
87.63-92.09

p<0.001

Table 2. Waist circumference: Men (elevated: ≥102cm, normal <102cm), Women (elevated: ≥88cm,
normal <88cm). LTPA: None, Some (≥1 but <150 minutes/week.), Meets Recommendations (≥150
minutes/week.) Q: Quartile; WC: Waist Circumference; MSA: Muscular strengthening activity; LTPA:
Leisure-time physical activity.
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Table 3. Odds for reporting no MSA in those without diabetes - 1999-2004 NHANES.
Variable
HOMA-IR
Q1
Q2
Q3
Q4
Age
20-29
30-39
40-49
50-59
≥60
Gender
Male
Female
Race
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other
School
College graduate
Some college
High school or GED
< High school
Smoking
Non-smoker
Former smoker
Smoker
Alcohol
Above moderate
Moderate
None
WC
Desirable
Elevated
LTPA
Meets Recommendations
Insufficient
None

Model 1a

Model 2b

Model 3c

1.00
1.27 (CI 0.96-1.68)
1.90 (CI 1.48-2.45)**
2.69 (CI 1.96-3.71)**

1.00
1.21 (CI 0.89-1.64)
1.59 (CI 1.13-2.23)**
2.00 (CI 1.37-2.91)***

1.00
1.25 (CI 0.88-1.77)
1.51 (CI 1.07-2.14)*
2.10 (CI 1.43-3.08)***

1.00
1.61 (CI 1.15-2.26)**
2.34 (CI 1.67-3.28)***
2.22 (CI 1.67-3.28)***
3.69 (CI 2.67-5.09)***

1.00
1.33 (CI 0.98-1.80)
2.23 (CI 1.59-3.13)***
1.96 (CI 1.39-2.78)***
3.10 (CI 2.26-4.24)***

1.00
1.43 (CI 1.14-1.80)**

1.00
1.51 (CI 1.06-1.63)*

1.00
0.74 (CI 0.51-1.06)**
1.36 (CI 0.94-1.98)
1.58 (CI 0.94-2.65)

1.00
0.58 (CI 0.40-0.84)**
1.14 (CI 0.77-1.67)
1.31 (CI 0.76-2.27)

1.00
1.53 (CI 1.16-2.03)**
2.41 (CI 1.84-3.16)***
3.40 (CI 2.07-5.57)***

1.00
1.32 (CI 0.97-1.80)
1.94 (CI 1.45-2.60)***
2.28 (1.41-3.67)**

1.00
1.19 (CI 0.89-1.60)
1.94 (CI 1.46-2.58)***

1.00
1.25 (CI 0.93-1.68)
1.64 (CI 1.26-2.14)***

1.00
1.19 (CI 0.83-1.59)
1.94 (CI 1.42-3.13)***

1.00
1.05 (CI 0.73-1.49)
1.90 (CI 1.28-2.82)**

1.00
1.55 (CI 1.30-1.84)***

1.00
1.44 (CI 1.17-1.77)***
1.00
3.16 (CI 2.49-4.01)***
8.02 (CI 5.92-10.87)***

Table 3. Waist circumference: Men (elevated: ≥102cm, normal <102cm), Women (elevated: ≥88cm,
normal <88cm). LTPA: None, Some (≥1 but <150 minutes/week.), Meets Recommendations (≥150
minutes/week.) ***p<0.001, **p<0.01, *p<0.05
a
Model 1: unadjusted. bModel 2: adjusted for age, race, gender, education, smoking status, alcohol
consumption, WC, and MSA. cModel 3: all covariates plus LTPA. WC: Waist Circumference; MSA:
Muscular strengthening activity; Q: Quartile; LTPA: Leisure-time physical activity
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Discussion
The results of this analysis show a positive association between quartiles of
HOMA-IR and the prevalence no self-reported MSA in euglycemic U.S. adults. This
study adds to previous traditional work investigating the relationship between MSA and
IR in healthy populations(9-16). Miller et al.(9) investigated the effects of a 10-week
resistance training (RT) program on basal insulin levels and insulin response to an
OGTT. Results revealed significant reductions in basal insulin levels (p<0.05) and insulin
levels in response to an OGTT (p<0.05) following the intervention. Another study
conducted by Craig et al.(12) revealed significant decreases in insulin response (p<0.05)
to an OGTT independent of age (31.8% younger, 32.6% elderly) in healthy subjects
completing a 12-week RT program. The current study findings support previous
prospective work, which indicates that MSA is inversely associated with IR.
Two cross-sectional studies have also shown an association between IR and
MSA(13,29). Churilla et al.(29) reported a significantly lowered odds (OR 0.71; 95% CI
0.54-0.93) for having impaired fasting glucose (IFG), suggesting normal β-cell function
in subjects reporting meeting the DHHS MSA recommendation compared to subjects
reporting no MSA. In another analysis using NHANES 1999-2004, Cheng et al.(13)
investigated the associations between MSA and insulin sensitivity (measured via
QUICKI(30)) in euglycemic subjects. Results revealed a significant difference in
QUCIKI levels for men and women reporting ≥1 day/week of MSA (p<0.05) compared
to those reporting none. Following adjustment for age, race/ethnicity, physical activity
other than MSA, BMI, smoking, alcohol consumption, and daily total caloric intake,
results remained significant in females but not males. Significance was only seen in

57

volumes of MSA ≥3 days/week (p<0.05) in males. The results of these studies further
indicate that MSA may be favorably associated with insulin sensitivity and glucose
control.
The aforementioned studies have all shown inverse associations between MSA
and IR in subjects without diabetes. However, our study investigated the associations
between increasing HOMA-IR quartiles and no self-reported MSA. This approach allows
for the potential clinical examination and interpretation of surveillance data. Few studies
have examined population based data using this method(17-21). Churilla et al.(21)
reported the prevalence of meeting the 2008 DHHS PA recommendations to 59.1%
among participants reporting high-cholesterol (HC) and 68.3% among participants not
reporting HC (p<0.05), suggesting those with elevated cholesterol levels may not be as
physically active as individuals with desirable levels. Another study by Churilla et al.(20)
reported significantly lowered odds (OR 0.85, 95% CI 0.82-0.88) for meeting the DHHS
PA recommendations in subjects with hypertension compared to those without
hypertension, again suggesting lower physical activity levels among hypertensive
individuals compared to those with desirable blood pressure values. Similar studies have
investigated diabetes and PA patterns(17,18). In a cross-sectional analysis using the
behavioral risk factor surveillance system (BRFSS), Zhao et al.(18) revealed that subjects
with diabetes reported lower levels of PA compared to those without diabetes. Also,
subjects with diabetes were less likely to report meeting the 2008 DHHS PA
recommendations compared to those without. These data suggest that subjects with
diabetes, high cholesterol, CHD, and hypertension may be less likely to engage in a
volume of PA that may prevent chronic diseases and promote health. Furthermore, the
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use of this novel clinical approach in surveillance research may allow clinicians (e.g.,
physicians, physician assistants, nurse practitioners) to better utilize their time with
patients who need lifestyle counseling and coaching. Our study suggests that subjects
with higher levels of IR (specifically the upper 50th percentile) have greater odds of
reporting no MSA. Results from the few clinical analyses and the current analysis may
begin to provide clinicians an understanding of behavioral patterns in population data,
thus revealing an increased need for recommendations in therapeutic lifestyle
interventions (PA, MSA, and dietary changes) within high risk or diseased populations.
The current prevalence estimates for engaging in adequate amounts of MSA are
approximately 21.9%-31.7%(31-34). Loustalot et al.(32) reported that 31.7% of
respondents reported participation in MSA ≥2 days/week. The most recent estimate,
using the 2011 BRFSS, is approximately 29.3%(34). From these data it can be estimated
that approximately 70% of U.S. adults are not engaging in adequate amounts of MSA.
Our study adds to these results specifically suggesting that eugluycemic subjects in the
upper quartile (81.19%, 95% CI 76.56-85.09) and third quartile (76.02%, 95% CI 71.0680.36) of IR have a significantly higher prevalence of reporting no MSA compared to
subjects in the lowest quartile (63.64%, 95% CI 58.69-68.31).
According to Barnes et al.(35) the prevalence of physicians recommending
exercise or PA to adult patients is approximately 32.4%. Moreover, subjects with disease
(e.g., diabetes, cardiovascular disease, cancer, hypertension) and subjects who were obese
had a greater prevalence compared to those without disease or those with a desirable
BMI. Despite this higher prevalence, Zhao et al.(18) showed that subjects with diabetes
have lower odds of reporting participation adequate PA. Interestingly, subjects with IR,
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who may have normal glucose levels, are in a state of increased risk for disease
development and there is no data currently reporting the prevalence of physician
recommended PA, specifically with IR status. Furthermore, our study results reveal the
importance of continuing research into this area in order to combat the increasing
incidence and prevalence of IR which has been shown to be highly associated with
increased risk for CVD(3,4), diabetes(1,36) and a number of adverse metabolic
conditions including obesity(37,38), dyslipidemia(39,40), inflammation(41) and
hypertension(42).
A recent review(43) investigating the role of MSA and the risk of CVD revealed
that MSA can improve insulin action, glucose response, reduce body fat and reduce
visceral adipose tissue; all of which are risk factors for CVD at abnormal levels. A recent
study by Grontved et al.(44), investigating the effects of MSA on type 2 diabetes,
revealed that men who participate in aerobic training (AT) and MSA for at least 150
minutes per week have a 59% reduction in risk for diabetes. Furthermore, a study
investigating MSA and risk for CHD by Tanasescu et al.(45) reported a 23% (RR 0.77,
p<0.05) reduction in risk for CHD in men who participated in at least 30 minutes of MSA
per week compared with men who did no MSA. These results suggest that participation
in routine PA, inclusive of MSA, could have a favorable impact on the risk for diabetes
(which has been shown to be a possible vascular equivalent to CVD) as well as CVD.
Due to the relationship between CVD and diabetes, as shown in a review by Grundy et
al.(46), it is imperative for health care professionals to suggest PA, inclusive of MSA, to
everyone capable of safely participating. Furthermore, due to the preventive effect MSA
has on diabetes and CVD risk, it is vital that adults in higher risk categories (i.e., higher
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levels of IR despite normal glucose levels), be counseled on therapeutic lifestyle changes,
including engaging in MSA.
The strengths of our study include strong external validity owing to the use of a
large representative sample and the use of validated assays to measure insulin, glucose
and glycosylated hemoglobin. Moreover, the novel approach to this study design,
characterized by utilizing IR as a predictor variable rather than an outcome, provides
insight into this relationship utilizing IR as the independent variable and health behavior
(MSA) as the dependent variable. The limitations of our study include the cross-sectional
study design, which does not allow for causation to be established, residual confounding,
and the use of questionnaires for the assessment of MSA, which may be subject to recall
bias.
Conclusions
Euglycemic adults that fall in the upper 50th percentile of HOMA-IR were more
likely to report no MSA independent of several covariates. Muscular strengthening
activity has been shown to improve insulin action, glycemic control, and reduce the risk
for CVD and type 2 diabetes. Thus, it may become increasingly important for health care
professionals to advocate MSA participation in all populations that can safely participate,
specifically those with higher levels of IR.
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Appendix B: Associations between HOMA-IR and adiposity measurements in
euglycemic U.S. adults: NHANES 1999-2004
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Background: Waist circumference (WC) and body mass index (BMI) have been shown
to be positively associated with insulin resistance (IR). The objective of this study was to
examine the associations between quartiles of the IR (using the homeostatic model
assessment of insulin resistance [HOMA-IR]) and BMI and WC in a nationally
representative sample of euglycemic U.S. adults.
Methods: Sample included adult participants (≥20 years of age) (N=2,442 [BMI model],
N=2,438 [WC model]) from the 1999-2004 National Health and Nutrition Examination
Survey (NHANES). HOMA-IR was categorized into quartiles. BMI and WC were
examined continuously as the dependent variables.
Results: Following adjustment for covariates, those with HOMA-IR values in the
second, third and fourth quartiles had significantly higher BMI’s (p<0.001) compared to
subjects in the first quartile. In the model using WC, significantly higher WC’s were
found in subjects in the second, third, and fourth quartiles of HOMA-IR (p<0.001)
compared to those in the first quartile. A significant linear trend was seen analyzing
HOMA-IR linearly (p<0.001) in both models.
Conclusions: Having a higher HOMA-IR value is associated with higher BMI and WC
values in euglycemic subjects.
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Insulin resistance (IR) is characterized by the inability of the body to properly
utilize endogenous insulin in an effective manner to maintain glucose homeostasis. The
homeostatic model assessment of IR (HOMA-IR) has been utilized as a measure for IR in
several epidemiological studies. Many studies have shown a significant association
between higher levels of IR and cardiovascular disease (CVD)(1-3); all-cause
mortality(4) as well as several cardio metabolic risk factors such as: inflammation(5,6)
high blood pressure(7,8) and dyslipidemia(7,9) in subjects without diabetes. Furthermore,
IR has been shown to be inversely associated with healthy lifestyle behaviors such as
physical activity (PA)(10,11). Balkau et al.(11) revealed a significant inverse association
between IR and PA independent of BMI and WC.
Insulin resistance is associated with adiposity, characterized by both body mass
index (BMI) (9,12-14) and waist circumference (WC)(14-17). In a study conducted by
Racette et al.(17), results revealed WC to be a stronger predictor of insulin sensitivity
compared to fitness. Riserus et al.(13) showed BMI to be a stronger predictor of insulin
sensitivity compared to PA, high-density lipoprotein cholesterol (HDL-C), saturated fat,
fasting glucose, triglycerides, diastolic blood pressure (DBP) and socioeconomic status.
Results from Nilsson et al.(16) revealed an elevated WC in women (>88 cm) to have a
similar predictive value for IR as the National Cholesterol Education Program (NCEP)
metabolic syndrome (MetS) definition.
While the relationship of adiposity and IR has been studied extensively, these
studies have utilized adiposity as an explanatory variable rather than the dependent
variable. This study investigated the associations between increasing levels of IR and
adiposity (BMI and WC) in nationally representative sample of euglycemic United States
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(U.S.) adults. To the extent of the author’s knowledge, this is the first study to investigate
these associations using a nationally representative sample from the National Health and
Nutrition Examination Survey (NHANES).
Methods
This study utilized six years of data from the 1999-2004 NHANES, a continuous
survey conducted by the National Center for Health Statistics(18). The NHANES was
designed to provide national estimates of the health and nutritional status of noninstitutionalized U.S. civilians over the age of two months. The final samples for this
study (N=2,475 [BMI model], N=2,475 [WC model]) met the following conditions: 1)
adult men and women ≥20 years of age; 2) attended a morning medical exam in a mobile
examination center following an eight to nine hour overnight fast; 3) if female, nonpregnant; 4) had complete data on all the variables of interest and 5) were without
diabetes (glycosylated hemoglobin <5.7%, and answered no to the question “Other than
during pregnancy, have you ever been told by a doctor or health professional that you
have diabetes or sugar diabetes?”).
Insulin Resistance
The independent variable was IR. We used the HOMA-IR as a measure for IR;
calculated via the equation by Matthews et al.(19): [fasting serum insulin (mU/ml) x
fasting plasma glucose (mmol/l)]/22.5. Age-adjusted quartiles of log-transformed
HOMA-IR were created using every 25th percentile based on weights specific to
NHANES: Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55).
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Adiposity
The dependent variables in the study were adiposity characterized by WC (cm)
and BMI (kg/m2). Body mass index and WC were taken from the BMX Body Measures
file (20) in NHANES and examined continuously. Adiposity measurements were
collected using methods from the Anthropometric Standardization Reference Manual
(21).
Covariates
Five categories of age were created: 20-29, 30-39, 40-49, 50-59 and ≥60. Gender
was categorized as either male or female. Four categories of race were created: nonHispanic White, non-Hispanic Black, Mexican American, and Other. Education was
categorized into four groups: less than high school, high school graduate or GED, some
college, and college graduate. Three categories of smoking were created: never smoked,
former smoker (quit within the last six-months), and current smoker. C-reactive protein
(CRP) was dichotomized: elevated (>3 and ≤10 mg/L) or normal (≤3 mg/L) (22).
Hypertension was defined as having a systolic blood pressure (SBP) ≥135mmHg or a
DBP ≥85mmHg or currently undergoing pharmacological treatment for hypertension
(23). Triglycerides were dichotomized as either elevated (≥150 mg/dl) or normal (<150
mg/dl)(23). Physical activity was categorized into three levels: none (0 min/week),
insufficient PA (1-150 min/week), and meeting the 2008 Department of Health and
Human Services (DHHS) PA recommendations (≥150 min/week) (24).
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Statistical Analysis
The data in this study were initially managed using SAS 9.2 (25). SAS was used
to conduct both complex variable recodes and data coding validation. SAS-callable
SUDAAN (26) was then used to conduct the analysis, incorporating sampling weights
within the context of the correlated multi-stage complex sampling design inherent to
NHANES. Non-overlapping 95% confidence intervals (CI) and corresponding p-values
illustrate significance (p<0.05). Linear regression (PROC REGRESS) analysis was used
to test the null hypotheses that individual regression coefficients are equal to zero for
each quartile of HOMA-IR. Two regression models were created; one for WC and one
for BMI. The model examining WC adjusted for age, race, gender, CRP, hypertension,
triglycerides, PA and HOMA-IR. The model examining BMI adjusted for age, race,
education, CRP, smoking, hypertension, triglycerides, PA and HOMA-IR. These two
models differed in the specific covariates used in order to achieve a parsimonious model
for each.
Results
Subjects with HOMA-IR values in the second, third and fourth quartiles had
significantly higher BMI’s (p<0.001) compared to subjects in the first quartile. In the
model using WC, significantly higher WC’s were found in subjects in the second, third,
and fourth quartiles of HOMA-IR (p<0.001) compared to those in the first quartile. A
significant linear trend was seen analyzing HOMA-IR linearly (p<0.001) in both models.
Table 1 summarizes the population characteristics.
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Table 1. Population characteristics of study sample, National Health and Nutrition
Examination Survey 1999-2004
Weighted % (SE)
N
HOMA-IR
Q1
Q2
Q3
Q4

2195
774
674
533

58.09 (1.52)
18.35 (0.83)
15.46 (0.80)
11.10 (0.72)

20-29
30-39
40-49
50-59
≥60

513
517
497
319
629

22.35 (1.88)
24.71 (1.41)
22.52 (1.17)
14.94 (0.91)
15.48 (1.03)

Male
Female

1279
1196

50.30 (0.94)
49.70 (0.94)

1329
394
594
158

75.01 (2.05)
9.02 (1.18)
7.18 (0.92)
8.78 (1.67)

510
672
563
730

25.69 (1.68)
29.93 (1.10)
25.78 (1.56)
18.60 (0.88)

1298
613
564

50.88 (1.90)
24.73 (1.42)
24.39 (1.50)

1759
716

73.83 (1.36)
26.17 (1.36)

1536
939

67.25 (1.08)
32.75 (1.08)

1871
604

76.29 (1.27)
23.71 (1.27)

976
691
808

33.15 (1.67)
29.88 (1.70)
36.97 (2.11)

Age

Gender
Race
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other
Education
College graduate
Some college
High school graduate/GED
< High school
Smoking
Never smoked
Former smoker
Current smoker
C-reactive protein
Normal
Elevated
Hypertension
Normotensive
Hypertension
Triglycerides
Normal
Elevated
Physical Activity
Meets recommendations
Insufficient
None

Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55). Hypertension: SBP ≥135mmHg
or a DBP ≥85mmHg. Normotensive: SBP <135mmHg and a DBP <85mmHg. CRP: elevated (>3 and ≤10
mg/L) or normal (≤3 mg/L). Triglycerides: elevated (≥150 mg/dl) or normal (<150 mg/dl) PA: None,
Insufficient (≥1 but <150 min/wk.), Meets Recommendations (≥150 min/wk.) HOMA-IR: homeostatic
model assessment of insulin resistance. SE: Standard error.
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Table 2 illustrates the results of the linear regression analysis examining the
associations between WC and independent variables among those without diabetes.
Following adjustment for covariates, significantly greater WC levels (β=19.44, p<0.001)
were observed in subjects in the greatest quartile of IR when compared to the other
quartiles. Subjects in the third quartile of IR, had significantly greater WC levels
(β=11.93, p<0.001) compared to the referent group and second quartile. Furthermore,
subjects in the second quartile of IR had significantly higher WC values (β=6.63,
p<0.001) compared to the referent group. When examining HOMA-IR linearly, a
significant relationship was revealed with WC (β=3.75, p<0.001).
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Table 2. β coefficients for regression analysis examining associations between HOMA-IR and waist
circumference in centimeters
Categorical Regression
Covariates
HOMA-IR
Q1
Q2
Q3
Q4
Age
20-29
30-39
40-49
50-59
≥60
Gender
Male
Female
Race
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other
C-reactive protein
Normal
Elevated
Hypertension
Normotensive
Hypertension
Triglycerides
Normal
Elevated
Physical Activity
Meets recommendations
Insufficient
None

Linear Regression

Waist Circumference
(95% CI)
β

Covariates

Waist Circumference
(95% CI)
β

HOMA-IR
0.00
6.63 (5.51,7.76)***
11.93 (10.64,13.21)***
19.44 (17.73,21.14)***

HOMA-IR

3.75 (2.75-4.76)***

20-29
30-39
40-49
50-59
≥60

0.00
2.30 (0.74,3.86)**
3.68 (1.99,5.36)***
5.99 (4.25,7.74)***
4.85 (2.92,6.79)***

Male
Female

0.00
-7.27 (-8.50,-6.04)***

Age
0.00
2.32 (0.64,3.99)**
3.48 (1.85,5.10)***
5.61 (4.02,7.20)***
4.58 (2.64,6.51)***
Gender
0.00
-7.21 (-8.34,-6.07)***
0.00
-1.30 (-2.83,0.22)
-2.43 (-4.02,-0.84)*
-2.44 (-5.05,0.16)
0.00
5.78 (4.53,7.02)***
0.00
2.38 (1.10,3.67)***
0.00
0.68 (-0.67,2.02)
0.00
0.70 (-0.53,1.92)
1.19 (0.41,1.97)**

Race
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other
C-reactive protein
Normal
Elevated
Hypertension
Normotensive
Hypertension
Triglycerides
Normal
Elevated
Physical Activity
Meets recommendations
Insufficient
None

0.00
-1.62 (-3.29,0.06)
-2.05 (-3.75,-0.34)*
-2.27 (-4.84,0.29)*
0.00
5.90 (4.62,7.18)***
0.00
2.51 (1.28,3.75)***
0.00
1.45 (0.23,2.67)*
0.00
1.15 (-0.22,2.52)
1.75 (0.71,2.80)***

Table 2. Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55). Hypertension: SBP
≥135mmHg or a DBP ≥85mmHg. Normotensive: SBP <135mmHg and a DBP <85mmHg. CRP: elevated
(>3 and ≤10 mg/L) or normal (≤3 mg/L). Triglycerides: elevated (≥150 mg/dl) or normal (<150 mg/dl) PA:
None, Insufficient (≥1 but <150 min/wk.), Meets Recommendations (≥150 min/wk.) ***p<0.001,
**p<0.01, *p<0.05. Model: adjusted for age, race, gender, CRP, hypertension, triglycerides, PA, HOMAIR. PA: Physical activity. CRP: C-reactive protein. HOMA-IR: homeostatic model assessment of insulin
resistance, CI: Confidence interval. β: Beta.
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Table 3 illustrates the results of the linear regression analysis examining the
associations between BMI and independent variables among those without diabetes.
Significant differences in BMI were revealed in subjects in the second (β=2.58, p<0.001),
third (β=4.37, p<0.001) and fourth (β=7.63, p<0.001) quartiles for IR compared to the
referent group. Furthermore, significant differences in BMI levels were found between
the second, third and fourth quartiles of HOMA-IR (p<0.001). Similar to WC, when
examining HOMA-IR linearly, a significant relationship was revealed with BMI (β=1.46,
p<0.001).
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Table 3. β coefficients for regression analysis examining associations between HOMA-IR and body
mass index in kg/m2
Categorical Regression
Covariates

Linear Regression

Body Mass Index
(95% CI)
β

HOMA-IR

Covariates

Body Mass Index
(95% CI)
β

HOMA-IR
Q1
Q2
Q3
Q4

0.00
2.58 (0.21,3.01)***
4.37 (3.86,4.88)***
7.63 (6.92,8.34)***

20-29
30-39
40-49
50-59
≥60

0.00
0.36 (-0.27,0.98)
0.33 (-0.40,1.06)
0.52 (-0.08,1.13)
-0.81 (-1.55,-0.06)*

Age

HOMA-IR

1.46 (1.08,1.84)***

20-29
30-39
40-49
50-59
≥60

0.00
0.39 (-0.22,1.01)
0.43 (-0.33,1.18)
0.68 (0.04,1.33)*
-0.70 (-1.40,-0.00)*

Age

Race
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other
Education
College graduate
Some college
High school graduate/GED
< High school
C-reactive protein
Normal
Elevated
Smoking
Never smoked
Former smoker
Current smoker
Hypertension
Normotensive
Hypertension
Triglycerides
Normal
Elevated
Physical Activity
Meets recommendations
Insufficient
None

0.00
0.94 (0.28,1.60)**
-0.23 (-0.92,0.46)
-0.17 (-1.24,0.91)
0.00
0.21 (-0.34,0.75)
0.37 (-0.12,0.87)
0.15 (-0.44,0.74)
0.00
2.28 (1.72,2.84)***
0.00
0.14 (-0.48,0.76)
-0.81 (-1.49,-0.13)*
0.00
1.03 (0.55,1.51)***
0.00
-0.02 (-0.47,0.44)
0.00
0.03 (-0.43,0.50)
0.04 (-0.34,0.42)

Race
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other
Education
College graduate
Some college
High school graduate/GED
< High school
C-reactive protein
Normal
Elevated
Smoking
Never smoked
Former smoker
Current smoker
Hypertension
Normotensive
Hypertension
Triglycerides
Normal
Elevated
Physical Activity
Meets recommendations
Insufficient
None

0.00
0.77 (0.11,1.44)*
-0.15 (-0.85,0.55)
-0.23 (-1.28,0.83)
0.00
0.37 (-0.24,0.97)
0.43 (-0.08,0.94)
0.33 (-0.42,1.07)
0.00
2.32 (1.71,2.59)***
0.00
0.10 (-0.50,0.70)
-0.96 (-1.71,-0.21)*
0.00
1.07 (0.56,1.59)***
0.00
0.26 (-0.18,0.70)
0.00
0.19 (-0.37,0.76)
0.24 (-0.27,0.74)

Table 3. Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55). Hypertension: SBP
≥135mmHg or a DBP ≥85mmHg. Normotensive: SBP <135mmHg and a DBP <85mmHg. CRP: elevated
(>3 and ≤10 mg/L) or normal (≤3 mg/L). Triglycerides: elevated (≥150 mg/dl) or normal (<150 mg/dl).
PA: None, Insufficient (≥1 but <150 min/wk.), Meets Recommendations (≥150 min/wk.) ***p<0.001,
**p<0.01, *p<0.05. Model: adjusted for age, race, education, smoking, CRP, hypertension, triglycerides,
PA, HOMA-IR. PA: Physical activity. CRP: C-reactive protein. HOMA-IR: homeostatic model
assessment of insulin resistance, CI: Confidence interval. β: Beta.
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Table 4 illustrates the mean WC and BMI level percentages across quartiles of
HOMA-IR. Furthermore, a significant difference was found in mean levels of WC
(second: third: 96.02, fourth: 102.92, p<0.01) and BMI (second: 26.35, third: 27.92,
fourth: 30.97, p<0.001) in the third and fourth quartiles of HOMA-IR compared to those
in the first quartile (WC: 91.14, BMI: 23.77). Moreover, significant differences were
found between subjects in the fourth quartile compared to those in the third quartile of
HOMA-IR (p<0.01) as well as between the second and third quartiles (p<0.01). Trend
analysis revealed a significant positive trend between BMI and quartiles of HOMA-IR
(p<0.001) as well as WC and quartiles of HOMA-IR (p<0.001). When examining the
relationship between adiposity measurement and HOMA-IR linearly, both BMI
(p<0.001) and WC (p<0.001) were found to have a significant positive linearly
relationship with HOMA-IR.
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Table 4. Means values of Waist Circumference (cm) and Body Mass Index (kg/m2) across quartiles of
HOMA-IR

HOMA-IR Quartile

WC means (95% CI)

BMI means (95% CI)

Q1

84.59 (83.87,85.32)

23.77 (23.53,24.00)

Q2

91.23 (90.55,91.90)

26.35 (26.00,26.69)

Q3

96.52 (95.41,97.63)

28.14 (27.67,28.60)

Q4

104.03 (102.40,105.66)

31.40 (30.73,32.07)

p<0.001

p<0.001

p<0.001

p<0.001

p-for-trend
(categorical
HOMA-IR)
p-for-trend
(linear HOMA-IR)

Q: Quartile; WC: Waist Circumference; BMI: Body Mass Index; kg/m2: Body weight in kilograms
divided by height in meters squared; HOMA-IR: Homeostatic model assessment of insulin
resistance; CI: Confidence interval; cm: Centimeters.
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Discussion
The results of this study illustrate a positive dose-response relationship between
HOMA-IR and two commonly utilized health indicators that have been shown to be
highly correlated with adiposity in euglycemic U.S. adults. Significantly greater values
for WC were seen in subjects falling in the second, third and fourth quartiles of HOMAIR compared to the first quartile. Similarly, significantly higher mean values for BMI
were seen in the second, third and fourth quartiles of HOMA-IR compared to the first
quartile. Our results add to existing cross-sectional studies investigating these
associations in U.S. adults(12,15-17,27). In a study of 4,800 Japanese men, Tabata et
al.(15) investigated the associations between increasing levels of WC and elevated
HOMA-IR. Compared to those with a WC <80 cm, subjects with a WC 80-84 cm (OR
3.2, 95% CI 2.3–4.3), 85-89 cm (8.2, 95% CI 6.1–11.0), 90-94 cm (15.2, 95% CI 11.1–
20.8), or ≥95 cm (45.2, 95% CI 31.8–64.4) were significantly more likely to have an
elevated HOMA-IR level.
The findings of this study are also consistent with several prospective(13,28,29)
and retrospective studies(30) as well as a randomized control trial(14). Wahrenberg et
al.(30) revealed that a WC ≥100 cm had a higher predictor value for IR measured by
HOMA-IR in males and females compared to a WC <100 cm. Furthermore, a higher
prevalence of IR (defined as HOMA-IR score >3.99) was found in subjects with a WC
≥100 cm (277 males; 388 females) compared to those <100 cm (7 males; 25 females).
Another study conducted by Riserus et al.(13) found BMI to be a stronger predictor of
insulin sensitivity compared to PA, HDL-C, saturated fat, fasting glucose, triglycerides,
DBP and socioeconomic status. Following exclusion of overweight and obese subjects,
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BMI remained the strongest predictor.
Increased levels of adiposity have been shown to be independently associated
with increased risk for many adverse health conditions such as CVD(31-33), coronary
heart disease(34), diabetes(33,35,36) as well as all-cause mortality(32). Furthermore,
adiposity has been shown in several studies to be associated with several CVD risk
factors such as hypertension(37,38), dyslipidemia(37,38), and MetS(37,39). Katzmarzyk
et al.(40) revealed an augmented WC (≥102 cm) to be associated with increased risk for
CVD, independent of having ≥2 MetS risk factors. Insulin resistance has also been shown
to be independently associated with CVD(1-3), all-cause mortality(4), and diabetes(3) as
well as several cardio metabolic risk factors such as: inflammation (5,6) high blood
pressure(7,8) and dyslipidemia(7,9); in subjects without diabetes. These results illustrate
the impact augmented levels of adiposity and IR can have on future CVD risk, even in
euglycemic subjects.
The results of our study revealed strong associations between HOMA-IR and
measurements of adiposity independent of PA. Several studies have shown inverse
associations between IR and PA(10,11) as well as PA and adiposity(41-43). A crosssectional analysis conducted by Balkau et al.(11) investigated the associations between
insulin sensitivity and PA in subjects without CVD and not treated with pharmacotherapy
for diabetes, hypertension, dyslipidemia, or obesity. Results revealed significant
associations between total activity and increased insulin sensitivity independent of BMI
and adiposity. While our study focused on the associations between IR and adiposity, no
significant mediating effects were seen, attributable to PA. Thus, our results speak to the
strength of association between IR and adiposity independent of PA, specifically in
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euglycemic subjects.
The strengths of our study include strong external validity owing to the use of a
large representative sample, consistent validated measurements for WC and BMI, and the
use of validated assays to measure insulin, glucose and glycosylated hemoglobin.
Additionally, our results are consistent with others demonstrating a positive relationship
between IR and adiposity. Finally, the novel approach to this study design, characterized
by utilizing HOMA-IR as the explanatory variable and adiposity measures as the
dependent variables provides further insight into this relationship. The limitations of our
study include the cross-sectional study design, which does not allow for causation to be
established between variables, and the use of questionnaires for the assessment of PA,
which is subject to recall bias.
Conclusions
In conclusion, adults without diabetes that fall in the 25th percentile and above of
HOMA-IR had greater WC values and those falling into the 25th percentile or higher of
HOMA-IR possessed greater BMI values compared to subjects in the lower 25th
percentile. Insulin resistance and increased adiposity have been shown to be
independently associated with increased risk for CVD, CHD, and diabetes. Our study
revealed that higher levels of IR are associated with increased WC and BMI, independent
of PA among euglycemic adults. Our study suggests that future research into the
deleterious relationships between IR and increased adiposity should consider the effects
in those considered euglycemic as well as the possible mediating effects of increased
volumes of PA.
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